✦ LIBER ✦

The use of HLA-I class superficial effector molecules expression for the prognosis of surgical results in patients with non small cell lung cancer (NSCLC)

✍ Scribed by Polotsky, B.E.; Laktionov, K.K.; Nikulitchev, L.A.; Gerasimov, S.S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HLA-I class superficial effector molecul

✍ Laktionov, K; Polotsky, B; Nikulitchev, L; Guerassimov, S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 102 KB

O-179 The Big Lung Trial (BLT): Determin

✍ Waller, David; Fairlamb, David J.; Gower, Nicole; Milroy, Robert; Peake, Michael 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Results of the phase I-II study of gemci

✍ Faivre, S; Monnerat, C; Raymond, E; Taieb, J; Adi Vago, N; Vicente-Azevedo, J; R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

The combination of gemcitabine and oxali

✍ V. Franciosi; R. Barbieri; G. Vasini; E. Aitini; C. Cacciani; R. Capra; F. Greco 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 182 KB

O-212 The Big Lung Trial (BLT): Determin

✍ Fairlamb, David J.; Spiro, Stephen G.; Gower, Nicole; Milroy, Robert; Peake, Mic 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Does Stereotactic Body Radiation Therapy

✍ A. Liss; A. Fakiris; J. Varlotto; L. Medford-Davis; J. Flickinger; J. Shelkey; J 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB